Home > Research > Publications & Outputs > Mometasone Furoate significantly reduces radiat...
View graph of relations

Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy: a double-blind randomized control trial in 120 patients

Research output: Contribution to journalMeeting abstract

Published

Standard

Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy : a double-blind randomized control trial in 120 patients. / Dunn, Kerry; Hindley, Andrew; Wood, Lisa; Sanneh, Alison; Barber, David; Whitehead, Anne; Zain, Zakiyah.

In: International Journal of Radiation Oncology - Biology - Physics, Vol. 87, No. 2 Supplement, 10.2013, p. S115.

Research output: Contribution to journalMeeting abstract

Harvard

Dunn, K, Hindley, A, Wood, L, Sanneh, A, Barber, D, Whitehead, A & Zain, Z 2013, 'Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy: a double-blind randomized control trial in 120 patients', International Journal of Radiation Oncology - Biology - Physics, vol. 87, no. 2 Supplement, pp. S115. https://doi.org/10.1016/j.ijrobp.2013.06.297

APA

Dunn, K., Hindley, A., Wood, L., Sanneh, A., Barber, D., Whitehead, A., & Zain, Z. (2013). Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy: a double-blind randomized control trial in 120 patients. International Journal of Radiation Oncology - Biology - Physics, 87(2 Supplement), S115. https://doi.org/10.1016/j.ijrobp.2013.06.297

Vancouver

Author

Dunn, Kerry ; Hindley, Andrew ; Wood, Lisa ; Sanneh, Alison ; Barber, David ; Whitehead, Anne ; Zain, Zakiyah. / Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy : a double-blind randomized control trial in 120 patients. In: International Journal of Radiation Oncology - Biology - Physics. 2013 ; Vol. 87, No. 2 Supplement. pp. S115.

Bibtex

@article{b5c45d3cbfea4e1898ef831bcee071e3,
title = "Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy: a double-blind randomized control trial in 120 patients",
abstract = "The most common acute side effect of patients receiving radiation therapy to the breast/chest wall is radiation induced dermatitis. Despite this, there is no accepted intervention to prevent or treat it. A previous study by Bostrom et al showed Mometasone Furoate (M) cream was superior to Diprobase (D) in a study of 50 breast cancer patients. We sought to repeat this study in a larger cohort of 120 patients.",
author = "Kerry Dunn and Andrew Hindley and Lisa Wood and Alison Sanneh and David Barber and Anne Whitehead and Zakiyah Zain",
year = "2013",
month = oct,
doi = "10.1016/j.ijrobp.2013.06.297",
language = "English",
volume = "87",
pages = "S115",
journal = "International Journal of Radiation Oncology - Biology - Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2 Supplement",
note = "American Society for Radiation Oncology ; Conference date: 22-09-2013 Through 25-09-2013",

}

RIS

TY - JOUR

T1 - Mometasone Furoate significantly reduces radiation dermatitis in patients undergoing breast radiation therapy

T2 - American Society for Radiation Oncology

AU - Dunn, Kerry

AU - Hindley, Andrew

AU - Wood, Lisa

AU - Sanneh, Alison

AU - Barber, David

AU - Whitehead, Anne

AU - Zain, Zakiyah

PY - 2013/10

Y1 - 2013/10

N2 - The most common acute side effect of patients receiving radiation therapy to the breast/chest wall is radiation induced dermatitis. Despite this, there is no accepted intervention to prevent or treat it. A previous study by Bostrom et al showed Mometasone Furoate (M) cream was superior to Diprobase (D) in a study of 50 breast cancer patients. We sought to repeat this study in a larger cohort of 120 patients.

AB - The most common acute side effect of patients receiving radiation therapy to the breast/chest wall is radiation induced dermatitis. Despite this, there is no accepted intervention to prevent or treat it. A previous study by Bostrom et al showed Mometasone Furoate (M) cream was superior to Diprobase (D) in a study of 50 breast cancer patients. We sought to repeat this study in a larger cohort of 120 patients.

U2 - 10.1016/j.ijrobp.2013.06.297

DO - 10.1016/j.ijrobp.2013.06.297

M3 - Meeting abstract

VL - 87

SP - S115

JO - International Journal of Radiation Oncology - Biology - Physics

JF - International Journal of Radiation Oncology - Biology - Physics

SN - 0360-3016

IS - 2 Supplement

Y2 - 22 September 2013 through 25 September 2013

ER -